Literature DB >> 12516201

The liver in heart failure.

Cosmas C Giallourakis1, Peter M Rosenberg, Lawrence S Friedman.   

Abstract

Severe congestive heart failure is associated with two distinct forms of liver dysfunction: jaundice that is related to passive congestion and acute hepatocellular necrosis that is caused by impaired perfusion. Cardiac cirrhosis (fibrosis) may result from prolonged recurrent congestive heart failure. Ischemic hepatitis (shock liver) usually manifests as asymptomatic elevation of the serum aminotransferase levels after an episode of hypotension, although the clinical presentation may mimic that of acute viral hepatitis. In most cases, ischemic hepatitis is of little clinical consequence and is self-limited. Acute liver failure may occur in patients with preexisting cirrhosis, severe chronic heart failure, or sustained hepatic ischemia.

Entities:  

Mesh:

Year:  2002        PMID: 12516201     DOI: 10.1016/s1089-3261(02)00056-9

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  68 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

3.  Acute liver failure as the first manifestation of severe traumatic tricuspid valve insufficiency.

Authors:  Apostolos Koroneos; John Vlachogiannakos; Konstantinos Stamoulis; Georgios Tassopoulos; Panagiotis Politis; Ioannis Floros; Charis Roussos
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

4.  Portal vein pulsatility index is a more important indicator than congestion index in the clinical evaluation of right heart function.

Authors:  Cheng-Yen Shih; Sien-Sing Yang; Jui-Ting Hu; Chin-Lin Lin; Yung-Chih Lai; Cheng-Wen Chang
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

5.  Hepatic dysfunction in hyperthyroidism.

Authors:  Saro Khemichian; Tse-Ling Fong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

6.  Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.

Authors:  Gardner L Yost; Laura Coyle; Geetha Bhat; Antone J Tatooles
Journal:  J Artif Organs       Date:  2015-07-18       Impact factor: 1.731

7.  Life-threatening variceal hemorrhage in a woman with severe pulmonary arterial hypertension.

Authors:  Bashar Almadani; Namita Sood; Martha Yearsley; William M Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

8.  Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension.

Authors:  Yasuko Takeda; Yutaka Takeda; Shigehiro Tomimoto; Tomomitsu Tani; Hitomi Narita; Genjiro Kimura
Journal:  BMC Pulm Med       Date:  2010-04-22       Impact factor: 3.317

9.  Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report.

Authors:  Chuan Shen; Cai-Yan Zhao; Fang Liu; Ya-Dong Wang; Jun Yu
Journal:  BMC Gastroenterol       Date:  2010-08-14       Impact factor: 3.067

10.  Liver failure in total artificial heart therapy.

Authors:  Alexandros Merkourios Dimitriou; Otto Dapunt; Igor Knez; Andrae Wasler; Peter Oberwalder; Reiner Koerfer; Gero Tenderich; Sotirios Spiliopoulos
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.